EGR1 and breast carcinoma: Several authors have reported that curcumin limits the migration/proliferation process of neoplastic breast cancer cells by inducing crosstalk between the anchoring junctions and the Wnt pathway by means of the EPR-1 factor (Early Growth Response 1), and by inhibiting the expression of several genes involved in the epithelial-mesenchymal transition (Epithelial mesenchymal transition-EMT) (such as β-catenin, Slug etc.), a process involved in cancer progression, thus suggesting its powerful anti-metastatic function52,53.